How to manage transitional clinical trials to the new European online portal, CTIS

The European clinical trial regulation establishes a three-year transition period in order to adapt to the new clinical studies’ online portal. In this article you will learn how to manage the transitions of your studies. It is essential that the sponsors and the CROs actively collaborate with each other in the transition strategy regarding CTIS, according to the different phases over the next three years

Welcome to our new website

New Sermes CRO website

We are delighted to announce the launch of our newly redesigned website. It reflects who Sermes CRO is and what we are capable of. The new website is modern and easy to navigate, it gives a clear message about who we are and a full services list. Don’t forget to check out our new blog. Pharmaceutical companies, biotechnologists and anyone interested in clinical research will find interesting articles there!

Azur Global Nutrition relies on Sermes CRO’s technological solutions

Azur Global Nutrition, leader in specialized solutions focused on immunonutrition, had many biological samples and clinical information coming from its research and development projects. They needed to organize and manage it in a systematic way. Sermes CRO then designed and created a personalized web portal that integrates application at user level and database. This solution allowed Azur Global Nutrition to work more efficiently, always measure their results and control the main process indicators

6 keys to understand the new European clinical trials portal (CTIS)

What changes to expect after CTIS implementation? What about timings and deadlines? What is the scope of CTR and CTIS? Should you set up a strategy for the transition period? Learn how to manage your clinical trials within the new European clinical research scenario reading the article.

Ethics Committees and CROs, a necessary pairing in clinical research

An interview with ANCEI, the Spanish National Association of Research Ethics Committees: “CROs play a preponderant role in the compliance of good clinical research practice standards. They perform an important function in a clinical trial start-up and in the proper monitoring of the conditions in which they are conducted”, explains the management board.